Page 947 - Williams Hematology ( PDFDrive )

922 Part VI: The Erythrocyte <CN>: <CT> PB

92. Ponka P, Schulman HM, Martinez-Medellin J: Haem inhibits iron uptake subsequent to 121. Gregg XT, Reddy V, Prchal JT: Copper deficiency masquerading as myelodysplastic
endocytosis of transferrin in reticulocytes. Biochem J 251(1):105–109, 1988. syndrome. Blood 100(4):1493–1495, 2002.
93. Campagna DR, de Bie CI, Schmitz-Abe K, et al: X-linked sideroblastic anemia due 122. Fong T, Vij R, Vijayan A, et al: Copper deficiency: An important consideration in the
to ALAS2 intron 1 enhancer element GATA-binding site mutations. Am J Hematol differential diagnosis of myelodysplastic syndrome. Haematologica 92(10):1429–1430,
89(3):315–319, 2014. 2007.
94. Bekri S, Kispal G, Lange H, et al: Human ABC7 transporter: Gene structure and muta- 123. Kumar N, Elliott MA, Hoyer JD, et al: “Myelodysplasia,” myeloneuropathy, and copper
tion causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic deficiency. Mayo Clin Proc 80(7):943–946, 2005.
iron-sulfur protein maturation. Blood 96(9):3256–3264, 2000. 124. Broun ER, Greist A, Tricot G, et al: Excessive zinc ingestion. A reversible cause of side-
95. Csere P, Lill R, Kispal G: Identification of a human mitochondrial ABC transporter, the roblastic anemia and bone marrow depression. JAMA 264(11):1441–1443, 1990.
functional orthologue of yeast Atm1p. FEBS Lett 441(2):266–270, 1998. 125. Patterson WP, Winkelmann M, Perry MC: Zinc-induced copper deficiency: Megamin-
96. Lill R, Muhlenhoff U: Iron-sulfur protein biogenesis in eukaryotes: Components and eral sideroblastic anemia. Ann Intern Med 103(3):385–386, 1985.
mechanisms. Annu Rev Cell Dev Biol 22:457–486, 2006. 126. Nusbaum NJ: Concise review: Genetic bases for sideroblastic anemia. Am J Hematol
97. Pondarre C, Campagna DR, Antiochos B, et al: Abcb7, the gene responsible for 37(1):41–44, 1991.
X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis. Blood 109(8): 127. Weatherall DJ, Pembrey ME, Hall EG, et al: Familial sideroblastic anaemia: Problem of
3567–3569, 2007. Xg and X chromosome inactivation. Lancet 2(7676):744–748, 1970.
98. Wingert RA, Galloway JL, Barut B, et al: Deficiency of glutaredoxin 5 reveals Fe-S 128. Cotter PD, May A, Fitzsimons EJ, et al: Late-onset X-linked sideroblastic anemia.
clusters are required for vertebrate haem synthesis. Nature 436(7053):1035–1039, Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in
2005. two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia
99. Camaschella C, Campanella A, De Falco L, et al: The human counterpart of zebraf- and ringed sideroblasts. J Clin Invest 96(4):2090–2096, 1995.
ish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 129. Furuyama K, Harigae H, Kinoshita C, et al: Late-onset X-linked sideroblastic anemia
110(4):1353–1358, 2007. following hemodialysis. Blood 101(11):4623–4624, 2003.
100. Ohgami RS, Campagna DR, Greer EL, et al: Identification of a ferrireductase 130. Buchanan GR, Bottomley SS, Nitschke R: Bone marrow delta-aminolaevulinate syn-
required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet thase deficiency in a female with congenital sideroblastic anemia. Blood 55(1):109–115,
37(11):1264–1269, 2005. 1980.
101. Pearson HA, Lobel JS, Kocoshis SA, et al: A new syndrome of refractory sideroblastic 131. Prasad AS, Tranchida L, Konno ET, et al: Hereditary sideroblastic anemia and glu-
anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. cose-6-phosphate dehydrogenase deficiency in a Negro family. J Clin Invest 47(6):1415–
J Pediatr 95(6):976–984, 1979. 1424, 1968.
102. Fontenay M, Cathelin S, Amiot M, et al: Mitochondria in hematopoiesis and hemato- 132. Beutler E: The distribution of gene products among populations of cells in heterozygous
logical diseases. Oncogene 25(34):4757–4767, 2006. humans. Cold Spring Harb Symp Quant Biol 29:261–271, 1964.
103. Andersen K, Kaad PH: Congenital sideroblastic anaemia with intrauterine symptoms 133. van Waveren Hogervorst GD, van Roermund HP, Snijders PJ: Hereditary sideroblastic
and early lethal outcome. Acta Paediatr 81(8):652–653, 1992. anaemia and autosomal inheritance of erythrocyte dimorphism in a Dutch family. Eur
104. Gattermann N: From sideroblastic anemia to the role of mitochondrial DNA mutations J Haematol 38(5):405–409, 1987.
in myelodysplastic syndromes. Leuk Res 24(2):141–151, 2000. 134. Fitzsimons EJ, May A: The molecular basis of the sideroblastic anemias. Curr Opin
105. Inoue S, Yokota M, Nakada K, et al: Pathogenic mitochondrial DNA-induced respira- Hematol 3(2):167–172, 1996.
tion defects in hematopoietic cells result in anemia by suppressing erythroid differenti- 135. Seip M, Gjessing LR, Lie SO: Congenital sideroblastic anaemia in a girl. Scand J Haema-
ation. FEBS Lett 581(9):1910–1916, 2007. tol 8(6):505–512, 1971.
106. Shin MG, Kajigaya S, Levin BC, et al: Mitochondrial DNA mutations in patients with 136. Horrigan DL, Harris JW: Pyridoxine-responsive anemia: Analysis of 62 cases. Adv
myelodysplastic syndromes. Blood 101(8):3118–3125, 2003. Intern Med 12:103–174, 1964.
107. Boultwood J, Pellagatti A, Nikpour M, et al: The role of the iron transporter ABCB7 in 137. Soslau G, Brodsky I: Hereditary sideroblastic anemia with associated platelet abnormal-
refractory anemia with ring sideroblasts. PLoS One 3(4):e1970, 2008. ities. Am J Hematol 32(4):298–304, 1989.
108. Bykhovskaya Y, Casas K, Mengesha E, et al: Missense mutation in pseudouridine syn- 138. Smith OP, Hann IM, Woodward CE, et al: Pearson’s marrow/pancreas syndrome: Hae-
thase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). matological features associated with deletion and duplication of mitochondrial DNA.
Am J Hum Genet 74(6):1303–1308, 2004. Br J Haematol 90(2):469–472, 1995.
109. Casas KA, Fischel-Ghodsian N: Mitochondrial myopathy and sideroblastic anemia. Am 139. Bishop RC, Bethell FH: Hereditary hypochromic anemia with transfusion hemosidero-
J Med Genet A 125A(2):201–204, 2004. sis treated with pyridoxine: Report of a case. N Engl J Med 261:486–489, 1959.
110. Drysdale J, Arosio P, Invernizzi R, et al: Mitochondrial ferritin: A new player in iron 140. Harris JW, Horrigan DL: Pyridoxine-responsive anemia—Prototype and variations on
metabolism. Blood Cells Mol Dis 29(3):376–383, 2002. the theme. Vitam Horm 22:721–753, 1964.
111. Levi S, Arosio P: Mitochondrial ferritin. Int J Biochem Cell Biol 36(10):1887–1889, 2004. 141. Vogler WR Mingioli ES. Heme synthesis in pyridoxine responsive anemia. N Engl J Med
112. Levi S, Corsi B, Bosisio M, et al: A human mitochondrial ferritin encoded by an intron- 273, 1965.
less gene. J Biol Chem 276(27):24437–24440, 2001. 142. Albahary C, Boiron M: [Primary refractory anemia with medullary and hepatic hyper-
113. Nie G, Sheftel AD, Kim SF, et al: Overexpression of mitochondrial ferritin causes cyto- siderosis of blood in a woman] [in French]. Acta Med Scand 163(5):429–438, 1959.
solic iron depletion and changes cellular iron homeostasis. Blood 105(5):2161–2167, 143. Horrigan DL: Pyridoxine-responsive anemia: Influence of tryptophan on pyridoxine
2005. responsiveness. Blood 42(2):187–193, 1973.
114. Cazzola M, Invernizzi R, Bergamaschi G, et al: Mitochondrial ferritin expression in 144. Yaouanq J, Grosbois B, Jouanolle AM, et al: Haemochromatosis Cys282Tyr mutation in
erythroid cells from patients with sideroblastic anemia. Blood 101(5):1996–2000, 2003. pyridoxine-responsive sideroblastic anaemia. Lancet 349(9063):1475–1476, 1997.
115. Singh AK, Shinton NK, Williams JD: Ferrokinetic abnormalities and their significance 145. French TJ, Jacobs P: Sideroblastic anaemia associated with iron overload treated by
in patients with sideroblastic anaemia. Br J Haematol 18(1):67–77, 1970. repeated phlebotomy. S Afr Med J 50(15):594–596, 1976.
116. Sharp RA, Lowe JG, Johnston RN: Anti-tuberculous drugs and sideroblastic anaemia. 146. Weintraub LR, Conrad ME, Crosby WH: Iron-loading anemia. Treatment with
Br J Clin Pract 44(12):706–707, 1990. repeated phlebotomies and pyridoxine. N Engl J Med 275(4):169–176, 1966.
117. Harriss EB, Macgibbon BH, Mollin DL: Experimental sideroblastic anaemia. Br J Hae- 147. Urban C, Binder B, Hauer C, et al: Congenital sideroblastic anemia successfully treated
matol 11:99–106, 1965. by allogeneic bone marrow transplantation. Bone Marrow Transplant 10(4):373–375,
118. Pierce HI, McGuffin RG, Hillman RS: Clinical studies in alcoholic sideroblastosis. Arch 1992.
Intern Med 136(3):283–289, 1976. 148. Medeiros BC, Kolhouse JF, Cagnoni PJ, et al: Nonmyeloablative allogeneic hematopoi-
119. McCurdy PR, Donohoe RF: Pyridoxine-responsive anemia conditioned by isonicotinic etic stem cell transplantation for congenital sideroblastic anemia. Bone Marrow Trans-
acid hydrazide. Blood 27(3):352–362, 1966. plant 31(11):1053–1055, 2003.
120. Dunlap WM, James GW 3rd, Hume DM: Anemia and neutropenia caused by copper 149. Yunis AA, Salem Z: Drug-induced mitochondrial damage and sideroblastic change.
deficiency. Ann Intern Med 80(4):470–476, 1974. Clin Haematol 9(3):607–619, 1980.

Kaushansky_chapter 59_p0915-0922.indd 922 9/17/15 3:18 PM